Tarig Elraiyah1, Mohamad Bassam Sonbol, Zhen Wang, Tagwa Khairalseed, Noor Asi, Chaitanya Undavalli, Mohammad Nabhan, Belal Firwana, Osama Altayar, Larry Prokop, Victor M Montori, Mohammad Hassan Murad. 1. Knowledge and Evaluation Research Unit (T.E., M.B.S., Z.W., T.K., N.A., C.U., M.N., B.F., O.A., V.M.M., M.H.M.), and Center for the Science of Healthcare Delivery (T.E., Z.W., N.A., M.H.M.), Mayo Clinic, Rochester, Minnesota 55905; Internal Medicine Department (M.B.S.), Georgia Regents University, Augusta, Georgia 30901; and Mayo Clinic Libraries (L.P.), Division of Endocrinology, Diabetes, Metabolism and Nutrition (V.M.M.), and Division of Preventive, Occupational, and Aerospace Medicine (M.H.M.), Mayo Clinic, Rochester, Minnesota 55905.
Abstract
CONTEXT: The use of T has been suggested to improve women's health during the postmenopausal period. OBJECTIVE: We conducted a systematic review and meta-analysis of randomized trials to summarize the best available evidence regarding the benefits and harms of systemic T in postmenopausal women with normal adrenal function. METHODS: A comprehensive search of MEDLINE, EMBASE, PsycInfo, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, EBSCO CINAHL, and Scopus was conducted through January 2014. We conducted study selection, data extraction, and appraisal in duplicate. Random-effects meta-analysis was used to pool results. RESULTS: We identified 35 randomized trials (n = 5053) at a moderate risk of bias. T use was associated with statistically significant improvement in various domains of sexual function and personal distress in postmenopausal women, although the majority of the trials did not have specific or contemporary diagnostic criteria for androgen deficiency in women. T use was also associated with a reduction in total cholesterol, triglyceride, and high-density lipoprotein and an increase in low-density lipoprotein and in the incidence of acne and hirsutism. No significant effect was noted on anthropometric measures and bone density. Long-term safety data were sparse, and the quality of such evidence was low. CONCLUSION: Despite the improvement in sexual function associated with T use in postmenopausal women, long-term safety data are lacking.
CONTEXT: The use of T has been suggested to improve women's health during the postmenopausal period. OBJECTIVE: We conducted a systematic review and meta-analysis of randomized trials to summarize the best available evidence regarding the benefits and harms of systemic T in postmenopausal women with normal adrenal function. METHODS: A comprehensive search of MEDLINE, EMBASE, PsycInfo, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, EBSCO CINAHL, and Scopus was conducted through January 2014. We conducted study selection, data extraction, and appraisal in duplicate. Random-effects meta-analysis was used to pool results. RESULTS: We identified 35 randomized trials (n = 5053) at a moderate risk of bias. T use was associated with statistically significant improvement in various domains of sexual function and personal distress in postmenopausal women, although the majority of the trials did not have specific or contemporary diagnostic criteria for androgen deficiency in women. T use was also associated with a reduction in total cholesterol, triglyceride, and high-density lipoprotein and an increase in low-density lipoprotein and in the incidence of acne and hirsutism. No significant effect was noted on anthropometric measures and bone density. Long-term safety data were sparse, and the quality of such evidence was low. CONCLUSION: Despite the improvement in sexual function associated with T use in postmenopausal women, long-term safety data are lacking.
Authors: Margaret E Wierman; Rosemary Basson; Susan R Davis; Sundeep Khosla; Karen K Miller; William Rosner; Nanette Santoro Journal: J Clin Endocrinol Metab Date: 2006-10-03 Impact factor: 5.958
Authors: Jonathan A C Sterne; Alex J Sutton; John P A Ioannidis; Norma Terrin; David R Jones; Joseph Lau; James Carpenter; Gerta Rücker; Roger M Harbord; Christopher H Schmid; Jennifer Tetzlaff; Jonathan J Deeks; Jaime Peters; Petra Macaskill; Guido Schwarzer; Sue Duval; Douglas G Altman; David Moher; Julian P T Higgins Journal: BMJ Date: 2011-07-22
Authors: Susan R Davis; Michele Moreau; Robin Kroll; Céline Bouchard; Nick Panay; Margery Gass; Glenn D Braunstein; Angelica Linden Hirschberg; Cynthia Rodenberg; Simon Pack; Helga Koch; Alain Moufarege; John Studd Journal: N Engl J Med Date: 2008-11-06 Impact factor: 91.245
Authors: Suzanne L West; Aimee A D'Aloisio; Robert P Agans; William D Kalsbeek; Natalie N Borisov; John M Thorp Journal: Arch Intern Med Date: 2008-07-14
Authors: Maria Almeida; Michaël R Laurent; Vanessa Dubois; Frank Claessens; Charles A O'Brien; Roger Bouillon; Dirk Vanderschueren; Stavros C Manolagas Journal: Physiol Rev Date: 2017-01 Impact factor: 37.312
Authors: C Mary Schooling; Shan Luo; Shiu Lun Au Yeung; Deborah J Thompson; Savita Karthikeyan; Thomas R Bolton; Amy M Mason; Erik Ingelsson; Stephen Burgess Journal: Int J Cardiol Date: 2018-05-18 Impact factor: 4.164
Authors: Sharon J Parish; James A Simon; Susan R Davis; Annamaria Giraldi; Irwin Goldstein; Sue W Goldstein; Noel N Kim; Sheryl A Kingsberg; Abraham Morgentaler; Rossella E Nappi; Kwangsung Park; Cynthia A Stuenkel; Abdulmaged M Traish; Linda Vignozzi Journal: J Womens Health (Larchmt) Date: 2021-04-01 Impact factor: 2.681
Authors: Paul Jonathan Roch; Danny Henkies; Jan Christoph Carstens; Carsten Krischek; Wolfgang Lehmann; Marina Komrakova; Stephan Sehmisch Journal: Front Endocrinol (Lausanne) Date: 2020-09-17 Impact factor: 5.555